News
-
-
-
COMMUNIQUÉ DE PRESSE
Medacta unveils the extended enhancements to its Hip Revision Platform
Medacta announces extended enhancements to its Hip Revision Platform in the European market to provide innovative solutions for complex procedures, including femoral and acetabular solutions with advanced features and medical education support -
-
-
COMMUNIQUÉ DE PRESSE
Medacta Hosts Inaugural Capital Markets Day, Showcasing Responsible Innovation and Effective Growth Strategy
Medacta Group SA hosts its first Capital Markets Day, presenting responsible innovation and effective growth strategy to investors. Key areas include patient-focused commitment, product development, and global market expansion -
-
-
COMMUNIQUÉ DE PRESSE
Medacta Group SA reports revenue growth of 14.3% at constant currency and adjusted EBITDA margin 26.9%, or 28.1% at constant currency in 1H 2024.
Medacta Group SA reports revenue growth of 14.3% at constant currency and adjusted EBITDA margin 26.9% in 1H 2024. Company showcases strong financial performance with new products and global expansion -
